Prevention and treatment of venous thromboembolism during pregnancy Journal Articles

abstract

• AbstractWomen who are pregnant or have recently given birth are at significantly increased risk of venous thromboembolism (VTE) compared with the general population. Furthermore, the issues surrounding the appropriate prevention, diagnosis, and treatment of VTE are more complex in pregnancy, where not only the effects on the mother, but also the effects on the fetus need to be considered. Although guidelines provide recommendations for the optimal management of these patients, most of these guidelines are based on evidence from observational studies, or on data extrapolated from a nonpregnant population. Randomized clinical trials are needed to identify the optimal strategies for prevention and treatment of VTE in pregnancy. © 2009 Wiley‐Liss, Inc.

authors

• Linkins, Lori-ann
• Weitz, Jeffrey

status

• published 

publication date

• July 2009

has subject area

• 1102 Cardiorespiratory Medicine and Haematology (FoR)
• Anticoagulants (MeSH)
• Cardiovascular System & Hematology (Science Metrix)
• Evidence-Based Medicine (MeSH)
• Female (MeSH)
• Fibrinolytic Agents (MeSH)
• Humans (MeSH)
• Practice Guidelines as Topic (MeSH)
• Pregnancy (MeSH)
• Pregnancy Complications, Cardiovascular (MeSH)
• Risk Assessment (MeSH)
• Risk Factors (MeSH)
• Treatment Outcome (MeSH)
• Venous Thromboembolism (MeSH)

published in

• Catheterization and Cardiovascular Interventions  Journal

keywords

• Anticoagulants
• Evidence-Based Medicine
• Female
• Fibrinolytic Agents
• Humans
• Practice Guidelines as Topic
• Pregnancy
• Pregnancy Complications, Cardiovascular
• Risk Assessment
• Risk Factors
• Treatment Outcome
• Venous Thromboembolism

Digital Object Identifier (DOI)

• 10.1002/ccd.21994

PubMed ID

• 19213066

start page

• S22

end page

• S26

volume

• 74

issue

• S1